Your browser doesn't support javascript.
loading
Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis.
Michalicková, Danica; Hrncír, Tomás; Canová, Nikolina Kutinová; Slanar, Ondrej.
Affiliation
  • Michalicková D; Institute of Pharmacology, First Faculty of Medicine & General University Hospital, Charles University, Prague, Czech Republic. Electronic address: danica.michalickova@lf1.cuni.cz.
  • Hrncír T; The Institute of Microbiology, The Czech Academy of Sciences, Novy Hradek, Czech Republic.
  • Canová NK; Institute of Pharmacology, First Faculty of Medicine & General University Hospital, Charles University, Prague, Czech Republic.
  • Slanar O; Institute of Pharmacology, First Faculty of Medicine & General University Hospital, Charles University, Prague, Czech Republic.
Eur J Pharmacol ; 873: 172973, 2020 Apr 15.
Article in En | MEDLINE | ID: mdl-32017935
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Vesicular Transport Proteins / NF-E2-Related Factor 2 / Kelch-Like ECH-Associated Protein 1 / Multiple Sclerosis Limits: Animals / Humans Language: En Journal: Eur J Pharmacol Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Vesicular Transport Proteins / NF-E2-Related Factor 2 / Kelch-Like ECH-Associated Protein 1 / Multiple Sclerosis Limits: Animals / Humans Language: En Journal: Eur J Pharmacol Year: 2020 Type: Article